Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL)

NYSEARCA: PILL · IEX Real-Time Price · USD
12.21
-0.12 (-0.97%)
At close: Aug 8, 2022 4:00 PM
12.50
+0.29 (2.38%)
Pre-market: Aug 9, 2022 8:46 AM EDT
-0.97%
Assets $14.78M
NAV $12.32
Expense Ratio 0.97%
PE Ratio n/a
Shares Out 1.20M
Dividend (ttm) $0.01
Dividend Yield 0.10%
Ex-Dividend Date Jun 22, 2022
1-Year Return -42.10%
Volume 30,040
Open 12.14
Previous Close 12.33
Day's Range 11.71 - 12.47
52-Week Low 8.05
52-Week High 23.69
Beta 2.59
Holdings 50
Inception Date Nov 15, 2017

About PILL

The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Asset Class Equity
Region North America
Issuer Direxion Investments
Stock Exchange NYSEARCA
Ticker Symbol PILL
Index Tracked Dynamic Pharmaceutical Intellidex Index

Top 10 Holdings

717081407.86% of assets
Name Symbol Weight
Pfizer PFE 717,081,103.00%
S&P PHARMACEUTICALS SELECT INDEX SWAP n/a 88.58%
S&P PHARMACEUTICALS SELECT INDEX SWAP n/a 86.18%
S&P PHARMACEUTICALS SELECT INDEX SWAP n/a 78.99%
DREYFUS GOVT CASH MGMT n/a 18.39%
GOLDMAN FINL SQ TRSRY INST 506 n/a 16.53%
GOLDMAN FS GOVT INST n/a 6.15%
DREYFUS GOVT CASH MGMT n/a 5.42%
Axsome Therapeutics AXSM 2.53%
Nektar Therapeutics NKTR 2.08%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Jun 22, 2022 $0.00361 Jun 29, 2022
Mar 22, 2022 $0.00817 Mar 29, 2022
Dec 21, 2021 $0.00007 Dec 29, 2021
Dec 23, 2019 $0.00033 Dec 31, 2019
Sep 24, 2019 $0.01521 Oct 1, 2019
Jun 25, 2019 $0.02237 Jul 2, 2019
Full Dividend History

News

Top Performing Leveraged/Inverse ETFs: 06/26/2022

Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Best Leveraged ETF Areas of Last Week

Wall Street was at the record high last week due to upbeat corporate earnings, strong jobs data and Pfizer's pill study.

3 ETFs to Access a Changing Pharmaceutical Industry

A changing pharmaceutical industry is setting up a few trades in the leveraged fund space, specifically for ETFs from Direxion Investments. One of the catalysts for change, especially within the past ye...

Other symbols: CUREWEBL

5 Best Leverage ETF Areas to Watch as Markets Bounces Back

Wall Street started the week on a shaky note due to a spike in U.S. COVID cases, which is a potential threat to economic reopening.

Other symbols: HIBLSILXSOXL

4 Best Leveraged ETFs of Last Week

Wall Street was moderate last week as rising rate concerns weighed on the stocks occasionally.

Other symbols: SOXLUCYB

3 Pharmaceutical ETFs That Could Be Due For A Rebound

These three pharmaceutical ETFs have dropped to support, which means they may be about to rebound. Support is a large concentration of buyers who have gathered around the same price level.

Other symbols: POTXXPH

PILL Hasn't Been a Bitter ETF to Swallow The Past Month

The Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (PILL) is up about 20% the past month, which is making it an easy pill to swallow for traders looking to capitalize on this sub-sector of h...

8 Leveraged ETFs That Added At Least 15% Last Week

Wall Street performed decently last week with the S&P 500, the Dow Jones and the Nasdaq Composite adding about 2.5%, 3.8% and 2.5%, respectively.

4 Best-Performing Leveraged ETF Areas of Last Week

Last week witnessed a tug-of-war between bulls and bears.

3 Leveraged Healthcare ETFs Soaring This Month

The new coronavirus from China has claimed more than 800 lives and there are now more than 37,000 documented cases of the respiratory illness worldwide, making it more deadly than the 2003 SARS epidemic.

Other symbols: CURELABU

7 ETFS That May Not Make It Through 2020

Forecasting the next funds to hit the ETF graveyard can be tricky as the decision to hit the “off” switch lies with the issuer, but a combination of low assets and weak volume usually is widely viewed a...

Other symbols: BDRY

5 Leveraged ETFs That Gained More Than 20% in October

We have highlighted five leveraged equity ETFs that piled up more than 20% returns in October and could continue to be investors' darlings.

Other symbols: BRZU

With Earnings On Tap, A Stir In This Leveraged Pharmaceuticals ETF

With pharmaceuticals stocks under intense political scrutiny this year, the Dynamic Pharmaceutical Intellidex Index (DZRTR) is lower by nearly 8% and is on pace for one of its worst annual performances ...